Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression

• Kevin Gaffney,
• Michael Weinberg,
• Maira Soto,
• Stan Louie,
• Kathleen Rodgers

Affiliations

Kevin Gaffney

Department of Pharmacology, University of Arizona, Tucson, AZ;Center for Innovation in Brain Science, University of Arizona, Tucson, AZ

Michael Weinberg

Titus Family Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA

Maira Soto

Department of Pharmacology, University of Arizona, Tucson, AZ;Center for Innovation in Brain Science, University of Arizona, Tucson, AZ

Stan Louie

Titus Family Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA

Kathleen Rodgers

Department of Pharmacology, University of Arizona, Tucson, AZ;Center for Innovation in Brain Science, University of Arizona, Tucson, AZ